BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38473739)

  • 1. Vaginal Lactobacilli Supernatants Protect from Herpes Simplex Virus Type 1 Infection in Cell Culture Models.
    Avitabile E; Menotti L; Giordani B; Croatti V; Parolin C; Vitali B
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal Lactobacillus gasseri CMUL57 can inhibit herpes simplex type 2 but not Coxsackievirus B4E2.
    Kassaa IA; Hober D; Hamze M; Caloone D; Dewilde A; Chihib NE; Drider D
    Arch Microbiol; 2015 Jun; 197(5):657-64. PubMed ID: 25752765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral effects of Lactobacillus crispatus against HSV-2 in mammalian cell lines.
    Mousavi E; Makvandi M; Teimoori A; Ataei A; Ghafari S; Samarbaf-Zadeh A
    J Chin Med Assoc; 2018 Mar; 81(3):262-267. PubMed ID: 29037754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of herpes simplex virus type 2 by vaginal lactobacilli.
    Conti C; Malacrino C; Mastromarino P
    J Physiol Pharmacol; 2009 Dec; 60 Suppl 6():19-26. PubMed ID: 20224147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaginal Lactobacilli Reduce
    Foschi C; Salvo M; Cevenini R; Parolin C; Vitali B; Marangoni A
    Front Cell Infect Microbiol; 2017; 7():502. PubMed ID: 29270390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of Vaginal Lactobacilli and Characterization of Anti-Candida Activity.
    Parolin C; Marangoni A; Laghi L; Foschi C; Ñahui Palomino RA; Calonghi N; Cevenini R; Vitali B
    PLoS One; 2015; 10(6):e0131220. PubMed ID: 26098675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial properties of Lactobacillus cell-free supernatants against multidrug-resistant urogenital pathogens.
    Scillato M; Spitale A; Mongelli G; Privitera GF; Mangano K; Cianci A; Stefani S; Santagati M
    Microbiologyopen; 2021 Feb; 10(2):e1173. PubMed ID: 33970542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exopolysaccharides from vaginal lactobacilli modulate microbial biofilms.
    Giordani B; Naldi M; Croatti V; Parolin C; Erdoğan Ü; Bartolini M; Vitali B
    Microb Cell Fact; 2023 Mar; 22(1):45. PubMed ID: 36890519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of HIV and HSV infection by vaginal lactobacilli in vitro and in vivo.
    Zabihollahi R; Motevaseli E; Sadat SM; Azizi-Saraji AR; Asaadi-Dalaie S; Modarressi MH
    Daru; 2012 Oct; 20(1):53. PubMed ID: 23351891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactobacilli extracellular vesicles: potential postbiotics to support the vaginal microbiota homeostasis.
    Croatti V; Parolin C; Giordani B; Foschi C; Fedi S; Vitali B
    Microb Cell Fact; 2022 Nov; 21(1):237. PubMed ID: 36376912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal and tumour cervical cells respond differently to vaginal lactobacilli, independent of pH and lactate.
    Motevaseli E; Shirzad M; Akrami SM; Mousavi AS; Mirsalehian A; Modarressi MH
    J Med Microbiol; 2013 Jul; 62(Pt 7):1065-1072. PubMed ID: 23618799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health.
    Chee WJY; Chew SY; Than LTL
    Microb Cell Fact; 2020 Nov; 19(1):203. PubMed ID: 33160356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterisation of vaginal lactobacilli from South African women.
    Pendharkar S; Magopane T; Larsson PG; de Bruyn G; Gray GE; Hammarström L; Marcotte H
    BMC Infect Dis; 2013 Jan; 13():43. PubMed ID: 23351177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro effect of vaginal lactobacilli against group B Streptococcus.
    Marziali G; Foschi C; Parolin C; Vitali B; Marangoni A
    Microb Pathog; 2019 Nov; 136():103692. PubMed ID: 31445119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of the two microorganisms Lactobacillus fermentum LF15 and Lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis: a pilot study.
    Vicariotto F; Mogna L; Del Piano M
    J Clin Gastroenterol; 2014; 48 Suppl 1():S106-12. PubMed ID: 25291116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal Lactobacilli Induce Differentiation of Monocytic Precursors Toward Langerhans-like Cells:
    Song J; Lang F; Zhao N; Guo Y; Zhang H
    Front Immunol; 2018; 9():2437. PubMed ID: 30410487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of Antibacterial and Technological Properties of Vaginal Lactobacilli for Their Potential Application in Dairy Products.
    Siroli L; Patrignani F; Serrazanetti DI; Parolin C; Ñahui Palomino RA; Vitali B; Lanciotti R
    Front Microbiol; 2017; 8():166. PubMed ID: 28223974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of vaginal lactobacilli in Chlamydia trachomatis infection.
    Mastromarino P; Di Pietro M; Schiavoni G; Nardis C; Gentile M; Sessa R
    Int J Med Microbiol; 2014 Jul; 304(5-6):654-61. PubMed ID: 24875405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of detection methods for vaginal lactobacilli.
    Smidt I; Kiiker R; Oopkaup H; Lapp E; Rööp T; Truusalu K; Štšepetova J; Truu J; Mändar R
    Benef Microbes; 2015; 6(5):747-51. PubMed ID: 25869280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of vaginal Lactobacillus strains with HeLa cells plasma membrane.
    Calonghi N; Parolin C; Sartor G; Verardi L; Giordani B; Frisco G; Marangoni A; Vitali B
    Benef Microbes; 2017 Aug; 8(4):625-633. PubMed ID: 28618863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.